$DHR news
The latest DHR stock news: headlines, filings, AI summaries and sentiment for $DHR, updated around the clock.
- Solventum Reports Q3 2026 Results Impacted by ERP Transition and Order Reversals
- Bio-Rad Reports Q3 2026 Results with Improved Margins Amid Life Science Challenges
- Danaher Subsidiary Cepheid Receives FDA Approval for Xpert Hemorrhagic Fever Panel
- Danaher Shares Rise Over 4% Following Third Quarter Earnings Beat and Raised Guidance
- Danaher Raises 2026 EPS Guidance and Forecasts Long-Term Core Growth
- Danaher Raises Full-Year EPS Guidance Following Strong Q3 2026 Results
- Danaher Reports Strong Q3 2026 Results Driven by Bioprocessing and Operational Execution
- Midday Market Update: SpaceX Revenue Surge and Super Micro Guidance Boost Stocks
- Market Outlook: SpaceX Gains and Super Micro Beat Drive Futures While Netflix and Abbott Lag
- Premarket Market Movers: SpaceX Revenue Surges and Super Micro Computer Raises Guidance
- Danaher Shares Fall Following Third Quarter Revenue Miss
- Danaher Reports Better-Than-Expected Non-GAAP Earnings, Misses Revenue Estimate
- DANAHER CORP /DE/ - 8-K Filing
- Major Earnings Releases Scheduled Before Market Open on Wednesday
- DANAHER CORP /DE/ - 8-K Filing
- Johnson & Johnson vs. Danaher: A Comparison of Healthcare Stock Performance Post-Earnings
- Avantor Stock Surges as VWR Segment Returns to Growth
- Danaher Stock Slump Seen as Potential Buying Opportunity Despite Earnings Report
- Thermo Fisher Stock Rises After Beating Second-Quarter Earnings Estimates
- Repligen to Acquire BioLife in $1.5 Billion Deal
- Danaher Reports Q2 2026 Earnings with Revenue Growth and Strategic Acquisitions
- Danaher Forecasts Core Revenue Growth for 2026 Following Masimo Acquisition
- Danaher Reports Strong Q2 Earnings and Raises Full-Year Guidance
- Danaher Stock Falls Despite Strong Q2 Earnings Beat
- Danaher Reports Q2 Earnings Beat with $1.94 Non-GAAP EPS
- DANAHER CORP /DE/ - 8-K Filing
- Abbott Outperforms Danaher as FreeStyle Libre Drives Growth Amid Slumping Biotech Demand
- Top medtech deals of H1 2026 highlight M&A activity and strategic shifts
- Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer
- Sirius XM Holdings to Replace Masimo in the S&P MidCap 400
- DANAHER CORP /DE/ - 8-K Filing
- Avantor Appoints Ludovic Brellier as Executive Vice President and Chief Transformation Officer
- Danaher Stock Underperforms Market Amid Mixed Q1 Results
- DANAHER CORP /DE/ - 8-K Filing
- ESAB Corp. Appoints R. Brent Jones as Chief Financial Officer
- Medtech Companies Increasingly Invest in AI Diagnostics Amid Market Growth
- Danaher Corporation Reports Q1 Adjusted EPS Beat
- Danaher Corporation Q1 2026 Earnings Call Summary
- Danaher Prices Euro-Denominated Senior Notes Offering
- Danaher (DHR) Q1 2026 Earnings Call Transcript
- Danaher Reports Q1 Earnings with Stronger Than Expected EPS and Mixed Segment Performance
- Danaher (DHR) Q1 2026 Earnings Call Highlights
- Danaher Corp. Positioned as a Beneficiary of Biotech Sector Recovery
- Danaher Raises 2026 Earnings Guidance, Shares Rise in Pre-Market Trading
- Danaher Reports Q1 Earnings Above Expectations and Raises FY26 Guidance